1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Inoue, K. Suetake, T. Hayashi, F. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution structure of the PDZ domain of human Rho guanine nucleotide exchange factor 11 10.2210/pdb2dls/pdb pdb_00002dls 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 9441.792 Rho guanine nucleotide exchange factor 11 PDZ domain 1 man polymer PDZ-RhoGEF no no GSSGSSGVQRCVIIQKDQHGFGFTVSGDRIVLVQSVRPGGAAMKAGVKEGDRIIKVNGTMVTNSSHLEVVKLIKSGAYVA LTLLGSSSGPSSG GSSGSSGVQRCVIIQKDQHGFGFTVSGDRIVLVQSVRPGGAAMKAGVKEGDRIIKVNGTMVTNSSHLEVVKLIKSGAYVA LTLLGSSSGPSSG A hsk002000370.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis ARHGEF11, KIAA0380 9606 Homo sapiens Cell free synthesis PLASMID P050919-12 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2006-10-20 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details HELIX Determination method: Author determined Y PDBJ Y PDBJ 2006-04-20 REL target function, structures with the lowest energy, structures with the least restraint violations 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 293 K torsion angle dynamics 1 lowest energy 1.20mM U-15N, 13C-labeled protein; 20mM d-Tris-HCl; 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 90% H2O, 10% D2O 90% H2O/10% D2O Varian collection VNMR 6.1C Delaglio, F. processing NMRPipe 20031121 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.93191 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 800 Varian INOVA GLY 1 n 1 GLY 1 A SER 2 n 2 SER 2 A SER 3 n 3 SER 3 A GLY 4 n 4 GLY 4 A SER 5 n 5 SER 5 A SER 6 n 6 SER 6 A GLY 7 n 7 GLY 7 A VAL 8 n 8 VAL 8 A GLN 9 n 9 GLN 9 A ARG 10 n 10 ARG 10 A CYS 11 n 11 CYS 11 A VAL 12 n 12 VAL 12 A ILE 13 n 13 ILE 13 A ILE 14 n 14 ILE 14 A GLN 15 n 15 GLN 15 A LYS 16 n 16 LYS 16 A ASP 17 n 17 ASP 17 A GLN 18 n 18 GLN 18 A HIS 19 n 19 HIS 19 A GLY 20 n 20 GLY 20 A PHE 21 n 21 PHE 21 A GLY 22 n 22 GLY 22 A PHE 23 n 23 PHE 23 A THR 24 n 24 THR 24 A VAL 25 n 25 VAL 25 A SER 26 n 26 SER 26 A GLY 27 n 27 GLY 27 A ASP 28 n 28 ASP 28 A ARG 29 n 29 ARG 29 A ILE 30 n 30 ILE 30 A VAL 31 n 31 VAL 31 A LEU 32 n 32 LEU 32 A VAL 33 n 33 VAL 33 A GLN 34 n 34 GLN 34 A SER 35 n 35 SER 35 A VAL 36 n 36 VAL 36 A ARG 37 n 37 ARG 37 A PRO 38 n 38 PRO 38 A GLY 39 n 39 GLY 39 A GLY 40 n 40 GLY 40 A ALA 41 n 41 ALA 41 A ALA 42 n 42 ALA 42 A MET 43 n 43 MET 43 A LYS 44 n 44 LYS 44 A ALA 45 n 45 ALA 45 A GLY 46 n 46 GLY 46 A VAL 47 n 47 VAL 47 A LYS 48 n 48 LYS 48 A GLU 49 n 49 GLU 49 A GLY 50 n 50 GLY 50 A ASP 51 n 51 ASP 51 A ARG 52 n 52 ARG 52 A ILE 53 n 53 ILE 53 A ILE 54 n 54 ILE 54 A LYS 55 n 55 LYS 55 A VAL 56 n 56 VAL 56 A ASN 57 n 57 ASN 57 A GLY 58 n 58 GLY 58 A THR 59 n 59 THR 59 A MET 60 n 60 MET 60 A VAL 61 n 61 VAL 61 A THR 62 n 62 THR 62 A ASN 63 n 63 ASN 63 A SER 64 n 64 SER 64 A SER 65 n 65 SER 65 A HIS 66 n 66 HIS 66 A LEU 67 n 67 LEU 67 A GLU 68 n 68 GLU 68 A VAL 69 n 69 VAL 69 A VAL 70 n 70 VAL 70 A LYS 71 n 71 LYS 71 A LEU 72 n 72 LEU 72 A ILE 73 n 73 ILE 73 A LYS 74 n 74 LYS 74 A SER 75 n 75 SER 75 A GLY 76 n 76 GLY 76 A ALA 77 n 77 ALA 77 A TYR 78 n 78 TYR 78 A VAL 79 n 79 VAL 79 A ALA 80 n 80 ALA 80 A LEU 81 n 81 LEU 81 A THR 82 n 82 THR 82 A LEU 83 n 83 LEU 83 A LEU 84 n 84 LEU 84 A GLY 85 n 85 GLY 85 A SER 86 n 86 SER 86 A SER 87 n 87 SER 87 A SER 88 n 88 SER 88 A GLY 89 n 89 GLY 89 A PRO 90 n 90 PRO 90 A SER 91 n 91 SER 91 A SER 92 n 92 SER 92 A GLY 93 n 93 GLY 93 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 12 A N VAL 12 A O LEU 81 A O LEU 81 A O THR 82 A O THR 82 A N ILE 54 A N ILE 54 A N VAL 56 A N VAL 56 A O THR 59 A O THR 59 A N THR 24 A N THR 24 A O GLN 34 A O GLN 34 1 A SER 5 -40.90 109.95 1 A GLN 18 -112.37 61.26 1 A SER 26 -171.00 129.54 1 A ASP 28 -73.89 -70.90 1 A VAL 33 -58.67 109.34 1 A SER 64 -39.08 158.30 2 A SER 2 37.62 42.48 2 A PHE 21 -35.97 151.28 2 A SER 26 -172.42 141.31 2 A SER 86 -43.97 155.16 2 A SER 88 -36.05 123.69 2 A PRO 90 -69.79 95.30 3 A LYS 16 -35.46 148.59 3 A ARG 37 -36.72 142.05 3 A PRO 38 -69.76 89.50 3 A ASN 63 -118.64 65.53 4 A GLN 18 -38.45 -31.53 4 A VAL 33 -46.41 106.54 4 A ARG 37 -38.65 140.64 4 A SER 75 -50.31 92.44 5 A SER 3 -171.11 134.53 5 A ASP 17 -131.49 -40.60 5 A GLN 18 -118.27 65.08 5 A ASP 28 -63.83 -70.17 5 A PRO 38 -69.75 82.19 5 A SER 64 -42.65 159.52 5 A LYS 74 -95.66 58.56 5 A SER 91 -47.26 160.42 6 A GLN 18 -134.99 -67.23 6 A ASP 28 -79.28 -74.84 6 A PRO 38 -69.77 99.29 6 A ALA 41 -124.33 -50.67 6 A ASN 63 71.05 33.51 7 A GLN 18 -109.35 42.79 7 A ARG 29 -106.48 -68.36 7 A ARG 37 -34.96 139.84 7 A PRO 38 -69.78 88.47 7 A VAL 61 -97.41 34.00 7 A SER 64 -43.90 150.78 8 A LYS 16 -38.91 137.22 8 A ASP 17 -107.57 -70.76 8 A THR 62 -132.03 -36.22 8 A LYS 74 -95.49 53.22 9 A SER 3 -99.26 -61.93 9 A SER 5 -38.11 131.81 9 A SER 26 -173.68 144.17 9 A PRO 90 -69.75 91.28 10 A GLN 18 -98.76 47.51 10 A PRO 38 -69.81 94.37 10 A VAL 61 -92.52 39.24 10 A LYS 71 -34.73 -39.99 10 A LYS 74 -90.49 46.74 10 A PRO 90 -69.80 89.04 10 A SER 92 -109.81 42.75 11 A SER 3 -51.94 94.97 11 A GLN 18 70.59 36.93 11 A ASP 28 -77.84 -71.07 11 A ARG 29 -71.14 -75.08 11 A ARG 37 -36.77 136.69 11 A PRO 38 -69.75 88.69 11 A SER 64 -43.78 161.64 11 A LYS 74 -42.68 -72.01 11 A SER 75 -47.64 106.56 11 A SER 88 36.76 51.00 12 A PHE 21 -65.25 -176.86 12 A ILE 30 -102.01 76.54 12 A VAL 31 -32.88 105.01 13 A SER 6 -68.17 88.71 13 A ASP 28 -70.85 -70.45 13 A VAL 33 -58.24 102.55 13 A LYS 74 -94.81 43.72 14 A LYS 16 -59.30 170.55 14 A PHE 21 -51.63 170.64 14 A ILE 30 -108.91 78.84 14 A SER 64 -37.10 154.34 14 A LEU 67 -38.00 -36.76 15 A SER 3 -57.50 171.93 15 A LYS 16 -34.62 118.13 15 A HIS 19 38.23 42.64 15 A PHE 21 -49.98 168.18 15 A VAL 31 -35.22 97.89 15 A VAL 33 -57.56 108.91 15 A PRO 38 -69.81 90.03 15 A HIS 66 -69.51 -70.24 15 A SER 88 -63.88 74.61 16 A SER 5 36.79 43.71 16 A PHE 21 -45.37 164.68 16 A VAL 31 -49.43 107.27 16 A ARG 37 -38.22 134.61 16 A PRO 38 -69.78 99.58 16 A ALA 41 -120.93 -52.49 16 A MET 60 -59.15 104.97 16 A HIS 66 -40.56 -71.98 16 A GLU 68 -39.24 -38.66 17 A ASP 28 -175.07 -179.19 17 A VAL 31 -33.19 128.38 17 A ARG 37 -36.61 139.56 17 A PRO 38 -69.73 90.17 17 A LYS 71 -36.66 -32.97 17 A LYS 74 -41.44 -73.57 17 A SER 75 -42.04 103.69 17 A SER 88 -34.65 127.00 17 A PRO 90 -69.77 2.70 18 A LYS 16 -34.47 107.87 18 A GLN 18 -111.66 50.39 18 A PHE 21 -56.05 174.60 18 A ASP 28 -76.18 -75.19 18 A ARG 29 -62.70 -73.36 18 A ARG 37 -36.06 135.97 18 A PRO 38 -69.74 82.48 18 A ASN 57 48.90 29.12 18 A SER 87 -130.79 -61.15 18 A SER 88 -50.83 103.11 18 A PRO 90 -69.82 95.66 19 A SER 2 35.29 40.96 19 A SER 5 -121.02 -59.10 19 A PRO 38 -69.71 3.61 19 A SER 75 -44.92 102.11 19 A SER 91 -34.55 131.02 20 A SER 3 -172.67 140.25 20 A SER 5 -132.47 -48.27 20 A ASP 28 -75.35 -70.85 20 A ARG 29 -66.11 -70.68 20 A ARG 37 -37.90 135.04 20 A SER 64 -51.98 -176.79 20 A LYS 74 -65.53 -71.86 20 A SER 75 -37.48 107.09 20 A ALA 77 -35.67 -34.70 Solution structure of the PDZ domain of human Rho guanine nucleotide exchange factor 11 1 N N A ALA 42 A ALA 42 HELX_P A ALA 45 A ALA 45 1 1 4 A SER 65 A SER 65 HELX_P A LYS 74 A LYS 74 1 2 10 SIGNALING PROTEIN PDZ domain, Rho guanine nucleotide exchange factor 11, PDZ-RhoGEF, ARHGEF11, KIAA0380, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, SIGNALING PROTEIN ARHGB_HUMAN UNP 1 44 O15085 44 123 2DLS 8 87 O15085 A 1 8 87 1 cloning artifact GLY 1 2DLS A O15085 UNP 1 1 cloning artifact SER 2 2DLS A O15085 UNP 2 1 cloning artifact SER 3 2DLS A O15085 UNP 3 1 cloning artifact GLY 4 2DLS A O15085 UNP 4 1 cloning artifact SER 5 2DLS A O15085 UNP 5 1 cloning artifact SER 6 2DLS A O15085 UNP 6 1 cloning artifact GLY 7 2DLS A O15085 UNP 7 1 cloning artifact SER 88 2DLS A O15085 UNP 88 1 cloning artifact GLY 89 2DLS A O15085 UNP 89 1 cloning artifact PRO 90 2DLS A O15085 UNP 90 1 cloning artifact SER 91 2DLS A O15085 UNP 91 1 cloning artifact SER 92 2DLS A O15085 UNP 92 1 cloning artifact GLY 93 2DLS A O15085 UNP 93 4 2 anti-parallel anti-parallel anti-parallel anti-parallel A GLN 9 A GLN 9 A GLN 15 A GLN 15 A TYR 78 A TYR 78 A LEU 84 A LEU 84 A ARG 52 A ARG 52 A VAL 56 A VAL 56 A THR 59 A THR 59 A MET 60 A MET 60 A PHE 23 A PHE 23 A SER 26 A SER 26 A LEU 32 A LEU 32 A VAL 36 A VAL 36